A double-blind, randomized phase 2 study comparing various doses (1, 5, 10, 15 mg) of once weekly tirzepatide, dulaglutide (1.5 mg) and placebo, in patients with T2DM, showed tirzepatide was superior on weight loss and glucose-lowering compared to both dulaglutide and placebo [52]
A primary advantage of the pill is that it does not require refrigeration, making it more convenient for travel. While most studies indicate that oral forms may be slightly less effective than injections, they remain very effective
Taking a smaller dose can help patients lose weight without lifestyle disruptions
The Primary Care Companion For CNS Disorders , 27 (3)
The remarkable, yet not extraordinary, human brain as a scaled-up primate brain and its associated cost
GLP-1 receptor agonists enhance glucose-dependent insulin secretion, meaning they help your pancreas release more insulin when blood sugar rises after meals